Insights into the knowledge, attitude and practices for the treatment of idiopathic inflammatory myopathy from a cross-sectional cohort survey of physicians

被引:0
作者
Latika Gupta
Hafis Muhammed
R. Naveen
Rajat Kharbanda
Harikrishnan Gangadharan
Durga P. Misra
James B. Lilleker
Hector Chinoy
Vikas Agarwal
机构
[1] Sanjay Gandhi Postgraduate Institute of Medical Sciences,Department of Clinical Immunology and Rheumatology
[2] Salford Royal NHS Foundation Trust,Manchester Centre for Clinical Neurosciences
[3] The University of Manchester,Division of Musculoskeletal and Dermatological Sciences, Centre for Musculoskeletal Research, School of Biological Sciences
[4] Manchester University NHS Foundation Trust,National Institute for Health Research Manchester Biomedical Research Centre
[5] The University of Manchester,Department of Rheumatology
[6] Salford Royal NHS Foundation Trust,undefined
[7] Manchester Academic Health Science Centre,undefined
来源
Rheumatology International | 2020年 / 40卷
关键词
Myositis; Questionnaire; Knowledge, attitudes, practice; Survey;
D O I
暂无
中图分类号
学科分类号
摘要
The idiopathic inflammatory myopathies (IIM) are heterogeneous and lead to high morbidity and mortality. Knowledge deficits among healthcare professionals could be detrimental to clinical care. Identifying areas of deficient Knowledge, Attitude and Practice (KAP) of IIM can improve physician education and patient outcomes. To assess the proportion of physicians treating IIM with poor KAP and identify the key areas of deficit. An anonymised and validated e-survey (57 questions) was circulated among physicians treating IIM (purposive sampling). Responses were evaluated using the Likert scale for good (> 70% correct response), poor (> 20% chose > 2 answers) and the rest as intermediate consensus. Descriptive statistics were used. Intergroup comparisons were done using non-parametric tests. Of 80 (9.1% of 883) respondents, 90% were rheumatologists and 37.5% academicians. The knowledge base of treating physicians was good in specific domains such as triggers (80–90%), clinical presentation (MDA5, statin myositis, steroid myopathy, anti-synthetase syndrome) (82–92%), IIM mimics (41–89%), investigations (23–92%) and risk of osteoporosis in IIM (79%). There is also an intermediate knowledge base/consensus for outcome measures (30–56%) and response criteria (30–53%). There was poor knowledge and consensus on trials (27–34%), EULAR/ACR criteria (31%) and exercise-based interventions (17–62%). While 90% agree on the need for muscle biopsy to diagnose polymyositis, only one-third advocated it for juvenile and adult DM. Physicians have a good understanding of the triggers, clinical presentation and mimics of IIM. Poor to intermediate knowledge and consensus exists regarding muscle biopsy, outcome measures, response criteria and exercise-based interventions, which could be addressed through future focussed educational initiatives.
引用
收藏
页码:2047 / 2055
页数:8
相关论文
共 69 条
[1]  
Bohan A(1975)Polymyositis and dermatomyositis N Engl J Med 292 344-347
[2]  
Peter JB(2016)Selected aspects of the current management of myositis Ther Adv Musculoskelet Dis 8 136-144
[3]  
Lilleker J(2020)Pitfalls in the diagnosis of myositis Best Pract Res Clin Rheumatol 34 101486-2003
[4]  
Murphy S(2019)Microsporidial myositis in adult-onset immunodeficiency: case-based review Rheumatol Int 39 1995-226
[5]  
Cooper R(2016)The diagnosis and treatment of antisynthetase syndrome Clin Pulm Med 23 218-232
[6]  
Chinoy H(2014)Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients Ann Rheum Dis 73 227-92
[7]  
Lilleker JB(2020)239th ENMC International Workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018 Neuromuscul Disord NMD 30 70-267
[8]  
Sundaram TG(2009)Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study Scand J Rheumatol 38 263-1981
[9]  
Aggarwal A(2019)Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review Rheumatol Int 39 1971-47
[10]  
Ganguly S(2018)Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study Ann Rheum Dis 77 40-52